Considerations in biomarker design

被引：0
|
作者：
Gundert-Remy, U [1 ]
机构：
[1] Fed Inst Risk Assessment, Berlin, Germany
来源：
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2004年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [1] Study Design Considerations for Cancer Biomarker Discoveries
    Zheng, Yingye
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2018, 3 (02): : 282 - 289
  • [2] Overview of Omics Biomarker Discovery and Design Considerations for Biomarker-Informed Clinical Trials
    Zhang, Weidong
    Huang, Bo
    Wang, Jing
    Menon, Sandeep
    BIOPHARMACEUTICAL APPLIED STATISTICS SYMPOSIUM, VOL 3: PHARMACEUTICAL APPLICATIONS, 2018, : 23 - 52
  • [3] Biomarker Enrichment Design Considerations in Oncology Single Arm Studies
    Tian, Hong
    Liu, Kevin
    PHARMACEUTICAL STATISTICS (MBSW 39), 2019, 218 : 203 - 214
  • [4] Design and analysis considerations for combining data from multiple biomarker studies
    Sloan, Abigail
    Song, Yue
    Gail, Mitchell H.
    Betensky, Rebecca
    Rosner, Bernard
    Ziegler, Regina G.
    Smith-Warner, Stephanie A.
    Wang, Molin
    STATISTICS IN MEDICINE, 2019, 38 (08) : 1303 - 1320
  • [5] Statistical Considerations of Optimal Study Design for Human Plasma Proteomics and Biomarker Discovery
    Zhou, Cong
    Simpson, Kathryn L.
    Lancashire, Lee J.
    Walker, Michael J.
    Dawson, Martin J.
    Unwin, Richard D.
    Rembielak, Agata
    Price, Patricia
    West, Catharine
    Dive, Caroline
    Whetton, Anthony D.
    JOURNAL OF PROTEOME RESEARCH, 2012, 11 (04) : 2103 - 2113
  • [6] Biomarker Clinical Trials in Lung Cancer: Design, Logistics, Challenges, and Practical Considerations
    Le-Rademacher, Jennifer
    Dahlberg, Suzanne
    Lee, J. Jack
    Adjei, Alex A.
    Mandrekar, Sumithra J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) : 1625 - 1637
  • [7] Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development
    Frantzi, Maria
    Bhat, Akshay
    Latosinska, Agnieszka
    CLINICAL AND TRANSLATIONAL MEDICINE, 2014, 3
  • [8] Biomarker Discovery and Validation: Statistical Considerations
    Ou, Fang-Shu
    Michiels, Stefan
    Shyr, Yu
    Adjei, Alex A.
    Oberg, Ann L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : 537 - 545
  • [9] Considerations in biomarker development for neurodevelopmental disorders
    McPartland, James C.
    CURRENT OPINION IN NEUROLOGY, 2016, 29 (02) : 118 - 122
  • [10] Design considerations
    Consult Specif Eng, 4 (45):
12345